Intranasal COVID-19 vaccine candidateï¾’s clinical data highlighted need for further development of nasal spray vaccines
On Oct. 11, 2022, researchers from the University of Oxford have reported new findings from a Phase 1…
On Oct. 11, 2022, researchers from the University of Oxford have reported new findings from a Phase 1…
On Oct. 7, 2022, the U.S. Food and Drug Administration approved Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and…
On Oct. 7, 2022, the U.S. Food and Drug Administration issued an Emergency Use Authorizationto Abbott Molecular, Inc.,…
On Oct. 7, 2022, the National Eye Institute researchers announced they had mapped the organization of human retinal…
On Oct. 6, 2022, Merck announced data from two real-world evidence studies evaluating LAGEVRIOï¾™ (molnupiravir), an investigational oral…
On Oct. 6, 2022, the World Health Organization announced the first cholera outbreak in nearly three decades in…
On Oct. 5, 2022, researchers at UC Berkeley reported that coccidioidomycosisï¾—also known as Valley feverï¾—an infectious disease, was…
On Oct. 5, 2022, the Nobel Prize in Chemistry was awarded jointly to Carolyn R. Bertozzi, Morten Meldal…
On Oct. 4, 2022, Washington University in St. Louis announced it had licensed the rights to develop, manufacture…
On Oct. 3, 2022, Monica M. Bertagnolli, M.D., started as the 16th director of the National Cancer Institute….
On Sept. 30, 2022, the U.S. Food and Drug Administration Modernization Act reauthorized the Prescription Drug User Fee…
On Sept. 28, 2022, Pfizer and BioNTech announced they had completed a submission to the European Medicines Agency…
On Sept. 23, 2022, researchers at Tufts University announced they had developed a method to make silk-based materials…
On Supt. 22, 2022, with a five-year, $126 million grant from the National Institutes of Health (NIH), a…
On Sept. 21, 2022, the AACR released the 12th edition of its AACR Cancer Progress Report, an annual…
On Sept. 20, 2022, the University of California, Davis announced that the amphibian decline in Latin America in…
On Sept. 15, 2022, Gilead Sciences announced updates to the World Health Organizationï¾’s Therapeutics and COVID-19: living guideline,…
On Sept. 15, 2022, the National Institutes of Health announced that a research team funded by the NIH…
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
On Sept. 13, 2022, the National Institutes of Health announced it will invest $130 million over four years,…
On Sept. 12, 2022, the White House announced an executive order to advance biotechnology and biomanufacturing towards innovative…
On Sept. 8, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service launched an updated…
On Sept. 8, 2022, researchers from the University of Oxford and their partners reported findings from their Phase…
On Sept. 7, 2022, Quest Diagnostics announced that it had received emergency use authorization (EUA) from the U.S….
On Sept. 6, 2022, scientists in China announced that they had conducted the first comprehensive study of the…
On Aug. 29, 2022, a group of international researchers, coordinated by Dr Jo�o Teixeira at The Australian National…
On Aug. 23, 2022, Pfizer and BioNTech announced updated efficacy results from a Phase 2/3 trial evaluating a…
On Aug. 23, 2022, Health authorities in the Democratic Republic of the Congo declared a resurgence of Ebola…
On Aug. 22, 2022, Pfizer and BioNTech announced they had completed a submission to the U.S. Food and…
On Aug. 18, 2022, the White House announced that the HHS had accelerated Phase 4 of its National…